NEO News and Press, NeoGenomics Inc. From 02/21/24

2024-02-21 10:06:26 ET NeoGenomics ( NASDAQ: NEO ) shares rose over 9% in morning trading on Wednesday after the cancer diagnostics firm forecast annual revenue above Wall Street estimates.... Read the full article on Seeking Alpha For further details see: NeoGenomic...

2024-02-21 08:22:42 ET Gainers: Sound Group  ( SOGP ) +113% Embraces Generative AI to Unveil New AI-Powered Applications. Origin Agritech  ( SEED ) +57% reports FY results CN Energy Group  ( CNEY ) +41% . Energy Focus  ( EF...

2024-02-20 19:20:21 ET NeoGenomics, Inc (NEO) Q4 2023 Results Conference Call February 20, 2024 04:30 PM ET Company Participants Kendra Sweeney - VP, IR Chris Smith - CEO Jeff Sherman - CFO Vishal Sikri - President, Advanced Diagnostics Warren Stone - Pre...

2024-02-20 16:28:02 ET More on NeoGenomics NeoGenomics: Progress, But A New Uncertainty NeoGenomics Q4 2023 Earnings Preview NeoGenomics ruling seen having limited impact on estimates, Needham says Seeking Alpha’s Quant Rating on NeoGenomics Hi...

Fourth Quarter Revenue Increased 12% to $156 million; Full Year Revenue Increased 16% to $592 million NeoGenomics, Inc. (Nasdaq: NEO) (the “Company”) , a leading provider of oncology testing and global contract research services, today announced fourth quarter and fu...

Kajima Corporation ADR (KAJMY) is expected to report for quarter end 2023-12-31 FaZe Holdings Inc. (FAZE) is expected to report for Q4 2023 BrewBilt MFG Inc (BBRW) is expected to report for Q4 2023 Correlate Energy Corp. (CIPI) is expected to report for Q4 2023 Hyzon Motors Inc. (...

2024-02-19 17:35:09 ET Major earnings expected after the bell on Tuesday include: Realty Income Corporation ( O ) Teladoc Health ( TDOC ) Palo Alto Networks ( PANW ) Chesapeake Energy Corporation ( CHK ) SolarEdge Technologies ( SEDG ) Read ...

2024-02-18 17:35:00 ET More on NeoGenomics NeoGenomics: Progress, But A New Uncertainty NeoGenomics ruling seen having limited impact on estimates, Needham says Natera wins court order barring NeoGenomics from selling RaDaR assay (update) Seeking Alpha’...

2024-02-04 10:07:53 ET Summary Today, we revisit NeoGenomics, a cancer genetics testing company,. The company is making progress around delivering sales growth and reducing losses.  The company has a potential new problem on the litigation front, however. What's ahead for...

NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced that the Company has signed the Working with Cancer Pledge . By taking the pledge, NeoGenomics demonstrates its commitment to supporting team members living with or caring for a loved one with cancer...